TG Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
TG Therapeutics (NASDAQ:TGTX) is set to release its quarterly earnings report on November 1, 2023. Analysts estimate an earnings per share (EPS) of $0.12. The company's past performance shows a mixed record of beating or missing EPS estimates. The stock price has increased by 30.15% over the last 52-week period.
October 31, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TG Therapeutics is expected to report an EPS of $0.12. The company's stock has seen a 30.15% increase over the last 52 weeks. The earnings report could impact the stock's performance.
The upcoming earnings report is a significant event for TG Therapeutics. The company's past performance shows a mixed record of beating or missing EPS estimates, which can influence the stock price. Given the 30.15% increase in the stock price over the last 52 weeks, investors are likely to be watching this earnings report closely.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100